With the impending election I failed to post about the U.S. Supreme Court case, Wyeth v. Levine, which was heard on Nov. 3.
Different attorneys and businesses are using different superlatives to describe the importance of the case, but suffice it to say that it’s a biggie.
I’ve blogged about the case before because the North Carolina Medical Society weighed in on the side of consumers. The issue is whether or not state laws can require stricter drug labeling than those required by the FDA.
It looks like the Justices will attempt to stake out a middle ground, which may or may not help those harmed by egregious medical errors.